[Therapeutic activity of a new combined topical drug (flumethasone pivalate, mineral tar, salicylic acid)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D003033:Coal Tar / Q000494:pharmacology*; D003872:Dermatitis / Q000188:drug therapy; D003879:Dermatologic Agents; D003875:Drug Eruptions / Q000188:drug therapy; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005443:Flumethasone / Q000627:therapeutic use; D005461:Fluorine; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008010:Lichen Planus / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011278:Pregnanes / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy; D012459:Salicylates / Q000627:therapeutic use*
D003879:Dermatologic Agents; D005938:Glucocorticoids; D011278:Pregnanes; D012459:Salicylates; D005461:Fluorine; D003033:Coal Tar; D005443:Flumethasone
Attività terapeutica di un nuovo preparato topico di associazione (pivalato di flumetasone, catrame minerale, acido salicilico)